Matthew Barcus
Stock Analyst at Chardan Capital
(0.58)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ZURA Zura Bio | Maintains: Buy | 12 10 | 1.41 | 609.22% | 3 | Mar 26, 2025 | |
QURE uniQure | Maintains: Buy | 45 27 | 14.13 | 91.08% | 4 | Jun 22, 2023 | |
XLO Xilio Therapeutics | Reiterates: Buy | 7 | 0.68 | 929.41% | 3 | May 30, 2023 | |
IMVT Immunovant | Maintains: Strong Buy | 21 32 | 14.76 | 116.8% | 4 | May 23, 2023 | |
PPBT Purple Biotech | Reiterates: Buy | 220 | n/a | n/a | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 144 126 | 0.93 | 13448.39% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 | 2.94 | 206.12% | 3 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 8 | 9.66 | -17.18% | 1 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | n/a | n/a | 3 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 21, 2022 |